A detailed history of Victory Capital Management Inc transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 10,371 shares of EDIT stock, worth $12,963. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,371
Previous 10,572 1.9%
Holding current value
$12,963
Previous $49,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$3.39 - $5.96 $681 - $1,197
-201 Reduced 1.9%
10,371 $35,000
Q2 2024

Aug 05, 2024

SELL
$4.67 - $7.28 $317,088 - $494,304
-67,899 Reduced 86.53%
10,572 $49,000
Q1 2024

May 03, 2024

BUY
$7.03 - $11.07 $474,848 - $747,734
67,546 Added 618.27%
78,471 $582,000
Q4 2023

Feb 05, 2024

BUY
$6.25 - $11.11 $68,281 - $121,376
10,925 New
10,925 $110,000
Q1 2022

May 04, 2022

SELL
$14.08 - $27.63 $15.7 Million - $30.8 Million
-1,115,611 Closed
0 $0
Q4 2021

Feb 07, 2022

SELL
$26.55 - $40.57 $87,561 - $133,799
-3,298 Reduced 0.29%
1,115,611 $29.6 Million
Q3 2021

Nov 02, 2021

BUY
$39.27 - $72.94 $42.3 Million - $78.5 Million
1,076,258 Added 2523.41%
1,118,909 $46 Million
Q2 2021

Aug 03, 2021

SELL
$31.29 - $56.64 $65,114 - $117,867
-2,081 Reduced 4.65%
42,651 $2.42 Million
Q1 2021

May 04, 2021

SELL
$39.71 - $90.58 $483,667 - $1.1 Million
-12,180 Reduced 21.4%
44,732 $1.88 Million
Q4 2020

Feb 01, 2021

SELL
$27.07 - $84.35 $245,145 - $763,873
-9,056 Reduced 13.73%
56,912 $3.99 Million
Q3 2020

Nov 09, 2020

BUY
$28.06 - $37.16 $234,329 - $310,323
8,351 Added 14.49%
65,968 $1.85 Million
Q2 2020

Aug 07, 2020

SELL
$18.5 - $34.34 $2.24 Million - $4.16 Million
-121,015 Reduced 67.75%
57,617 $1.7 Million
Q1 2020

May 04, 2020

SELL
$14.88 - $32.78 $102,344 - $225,460
-6,878 Reduced 3.71%
178,632 $3.54 Million
Q4 2019

Feb 06, 2020

BUY
$19.49 - $32.63 $42,800 - $71,655
2,196 Added 1.2%
185,510 $5.49 Million
Q4 2019

Feb 04, 2020

SELL
$19.49 - $32.63 $351,326 - $588,188
-18,026 Reduced 8.95%
183,314 $4.85 Million
Q3 2019

Nov 12, 2019

BUY
$22.49 - $26.81 $4.53 Million - $5.4 Million
201,340 New
201,340 $4.58 Million
Q1 2019

May 03, 2019

SELL
$19.43 - $26.41 $1.2 Million - $1.64 Million
-62,002 Closed
0 $0
Q4 2018

Feb 05, 2019

BUY
$18.19 - $31.79 $305,592 - $534,072
16,800 Added 37.17%
62,002 $1.41 Million
Q3 2018

Nov 01, 2018

SELL
$27.65 - $38.39 $66,913 - $92,903
-2,420 Reduced 5.08%
45,202 $1.44 Million
Q2 2018

Aug 02, 2018

SELL
$31.4 - $41.01 $83,838 - $109,496
-2,670 Reduced 5.31%
47,622 $1.71 Million
Q1 2018

May 04, 2018

BUY
$29.84 - $44.08 $165,910 - $245,084
5,560 Added 12.43%
50,292 $1.67 Million
Q4 2017

Feb 01, 2018

BUY
$21.89 - $31.34 $107,698 - $154,192
4,920 Added 12.36%
44,732 $1.38 Million
Q3 2017

Oct 27, 2017

SELL
$15.81 - $24.01 $32,252 - $48,980
-2,040 Reduced 4.87%
39,812 $956,000
Q2 2017

Aug 07, 2017

BUY
N/A
41,852
41,852 $702,000

Others Institutions Holding EDIT

About Editas Medicine, Inc.


  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $85.9M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.